The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions.
|Original language||English (US)|
|Number of pages||3|
|Journal||Infection Control and Hospital Epidemiology|
|State||Published - Jun 1 2017|
Bibliographical notePublisher Copyright:
© 2017 by The Society for Healthcare Epidemiology of America. All rights reserved.